Jeil Pharmaceutical Company Limited (002620) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Jeil Pharmaceutical Company Limited Company Snapshot

Business Description:

Jeil Pharmaceutical Company Limited operates in the Medicinals and botanicals sector. Jeil Pharmaceutical Co.,Ltd is a Korea-based company engaged in the manufacture and sale of pharmaceutical products. The Company's products include duodenum ulcer treatments, antibiotics, polyuria remedies, anischuria remedies, sepsis treatments, impetigo remedies, acute bronchitis remedies, hypochondria treatments, antiphlogistics and treatments for stomach ulcer. The Company also distributes hyperlipoidemia treatments, neuromuscular disorder treatments and antihypertensive agents, as well as researches and develops remedies for diabetes, asthma and cancer. In our complete report available for purchase the company is compared to: Jw Pharmaceutical Corp, LG Life Sciences Ltd and Handok Pharmaceuticals Co., Ltd..

Jeil Pharmaceutical Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 13,500
(Figures in Korean Won)

1 Week	-1.5%	13 Weeks	-3.6%

4 Weeks	16.4%	52 Weeks	14.4%

Jeil Pharmaceutical Company Limited Key Data:

Ticker:	002620	Country:	KOREA (SOUTH)

Exchanges:	SEO	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	431,307,030,000 (Year Ending Jan 2011).	Employees:	894

Currency:	Korean Won	Market Cap:	176,045,400,000

Fiscal Yr Ends:	December	Shares Outstanding:	13,040,400

Share Type:	Common	Closely Held Shares:	7,396,783

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.